메뉴 건너뛰기




Volumn 87, Issue 8, 1993, Pages 609-620

Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhaler

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE;

EID: 0027519906     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(05)80264-1     Document Type: Article
Times cited : (110)

References (16)
  • 1
    • 0001472424 scopus 로고
    • British Thoracic Society and others-Guidelines for management of asthma in adults: I-chronic persistent asthma
    • (1990) BMJ , vol.301 , pp. 651-653
  • 5
  • 8
    • 0025092716 scopus 로고
    • Structure-activity relationships of topically active steroids: the selection of fluticasone propionate
    • (1990) Respiratory Medicine , vol.84 , pp. 19-23
    • Phillips, GH1
  • 9
    • 4244025444 scopus 로고
    • Fluticasone propionate (a new inhaled steroid): clinical developments in mild to moderate adult asthmatics
    • S924 (abstract)
    • (1990) Eur Respir J , vol.3 , pp. 250s
    • Svendsen, UG1
  • 13
    • 0000386688 scopus 로고
    • Misuse of inhaled bronchodilator agents
    • (1965) BMJ , vol.1 , pp. 1037-1038
    • Saunders, KB1
  • 16
    • 0026636419 scopus 로고
    • Inhaled corticosteroids: benefits and risks
    • (1992) Thorax , vol.47 , pp. 404-407
    • Geddes, DM1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.